Publications - John K . Camoriano, M.D.

Back to Research Profile

1. Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res 2009 Sep; 33(9):1199-203. Epub 2009 Feb 27.
   View PubMed
2. Steensma DP, Heptinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack J, Bennett JM, Mesa RA. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. Leuk Res 2008 May; 32(5):691-8. Epub 2007 Dec 04.
   View PubMed
3. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial. Int J Gastrointest Cancer 2008 Jan 03. [Epub ahead of print]
   View PubMed
4. Mesa RA, Camoriano JK, Geyer SM, Wu W, Kaufmann SH, Rivera CE, Erlichman C, Wright J, Pardanani A, Lasho T, Finke C, Li CY, Tefferi A. A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia. Leukemia 2007 Sep; 21(9):1964-70. Epub 2007 Jun 21.
   View PubMed
5. Mesa R, Camoriano J, Geyer S, Wu W, Kaufmann S, Rivera C, Erlichman C, Finke J, Li C, Tefferi A. A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocytopenia. Leukemia (Advance Online Publication) doi:10.1038/sj.leu.2404816 21 June 2007.
   View PubMed
6. Haddock MG, Swaminathan R, Foster NR, Hauge MD, Martenson JA, Camoriano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DF Jr, Alberts SR. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol 2007 Jun 20; 25(18):2567-72.
   View PubMed
7. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Ruiz-Delgado GJ, Rosillo C, Camoriano JK. Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia. Am J Hematol 2007 May; 82(5):400-2.
   View PubMed
8. Mesa RA, Niblack J, Wadleigh M, Verstovsek S, Camoriano J, Barnes S, Tan AD, Atherton PJ, Sloan JA, Tefferi A. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - an international internet-based survey of 1179 MPD patients. Cancer 2007 Jan 1; 109(1):68-76.
   View PubMed
9. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NCP, Gilliland DG, Kantarjian H. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006 Sep 1; 108(5):1497-503.
   View PubMed
10. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA Jr, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H, International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood 2006 Sep 1; 108(5):1497-503. Epub 2006 May 04.
    View PubMed
11. Pardanani A, Ketterling RP, Li CY, Patnaik MM, Wolanskyj AP, Elliott MA, Camoriano JK, Butterfield JH, Dewald GW, Tefferi A. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Leuk Res 2006 Aug; 30(8):965-70. Epub 2006 Jan 06.
    View PubMed
12. Delaunoit T, Burch PA, Reid JM, Camoriano JK, Kobayash T, Braich TA, Kaur JS, Rubin J, Erlichman C. A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors. Invest New Drugs 2006 Jul; 24(4):327-33.
    View PubMed
13. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PAS, Nikcevich DA, Perez EA. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group trial N0032. J Clin Oncol 2006 Mar 1; 24(7):1052-6.
    View PubMed
14. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PA, Nikcevich DA, Perez EA, North Central Cancer Treatment Group Trial N0032. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. J Clin Oncol 2006 Mar 1; 24(7):1052-6.
    View PubMed
15. Bobis KG, Camoriano JK, Wright MJ. The Office of Advanced Technology: providing focus on the piloting and implementation of new technology. J Healthc Inf Manag 2004; 18(4):27-32.
    View PubMed
16. Bobis KG, Camoriano J. Managing technology in a physician-led organization. J Healthc Inf Manag 2003 Spring; 17(2):24-31.
    View PubMed
17. Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood 2002 May 15; 99(10):3854-6.
    View PubMed
18. Burch PA, Richardson RL, Cha SS, Sargent DJ, Pitot HC 4th, Kaur JS, Camoriano JK. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer. J Urol 2000 Nov; 164(5):1538-42.
    View PubMed
19. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999 Oct; 17(10):3299-306.
    View PubMed
20. Harold KL, Schlinkert RT, Mann DK, Reeder CB, Noel P, Fitch TR, Braich TA, Camoriano JK. Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura. Mayo Clin Proc 1999 Jan; 74(1):37-9.
    View PubMed
21. Witzig TE, Camoriano JK, Schroeder G, Kurtin PJ, Habermann TM. A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma. Leukemia & Lymphoma 1998 Jan; 28(3-4):307-14.
    View PubMed
22. Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial. Am J Clin Oncol 1997 Oct; 20(5):500-4.
    View PubMed
23. Colon-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Cancer J Sci Am 1997 Sep-Oct; 3(5):297-302.
    View PubMed
24. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer 1997 Jul 15; 80(2):218-24.
    View PubMed
25. Loprinzi Dl, Ghosh C, Camoriano JK, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III Controlled Evaluation of Sucralfate to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy. J Clin Oncol 1997 Mar; 15(3):1235-8.
    View PubMed
26. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 1997 Mar; 15(3):1235-8.
    View PubMed
27. Halyard MY, Camoriano JK, Culligan JA, Weiland LH, Allen MS, Pluth JR, Pairolero PC. Malignant fibrous histiocytoma of the lung. Report of four cases and review of the literature. Cancer 1996 Dec 15; 78(12):2492-7.
    View PubMed
28. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, Habermann TM, Parwaresch R. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin- embedded lymph node biopsies. Am J Clin Pathol 1996 Mar; 105(3):268-76.
    View PubMed
29. Gharagozloo F, Dausmann MJ, Whitaker MD, Camoriano JK, Parish JM, McReynolds SD, Hall KA, Pluth JR. Thorascopic excision of a peripheral corticotropin-secreting pulmonary carcinoid tumor. Mayo Clin Proc 1994 Jun; 69:594-6.
    View PubMed
30. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992 Sep; 5(5):525-30.
    View PubMed
31. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990 Aug; 8(8):1327-34.
    View PubMed
32. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989 Dec; 34(12):1937-42.
    View PubMed
33. van Haelst-Pisani CM, Gleich GJ, Leiferman KM, Sorenson JM, Camoriano JK, Schray AG, O'Connell MJ, Kovah JS. Eosinophil Major Basic Protein as a Marker of IL-2 Induced Eosinophil Degranulation in Man. Proceedings of ASCO 1989 Mar; 8:700.
34. Arnold RW, Adams BA, Camoriano JK, Dyer JA. Acquired divergent strabismus: presumed metastatic gastric carcinoma to the medial rectus muscle. Journal of Pediatric Ophthalmology & Strabismus 1989 Jan-Feb; 26(1):50-1.
    View PubMed
35. Camoriano JK, Greipp PR, Bayer GK, Bowie EJ. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy. N Engl J Med 1987 Apr 30; 316(18):1133-5.
    View PubMed